Dogs share overlapping gut microbial taxonomy, gene content, and functional pathways with humans — a similarity shaped by co-habitation, shared dietary exposures, and convergent evolutionary pressures. Canine cohorts spontaneously develop obesity-related metabolic dysfunction, chronic enteropathies, cognitive decline, and cancers under ecologically realistic conditions, with breed-stratified lifespans enabling repeated longitudinal sampling across disease progression timelines impractical to replicate in human trials.
This review arrives at a moment when microbiome science urgently needs better translational bridges. Rodent gnotobiotic models offer tight experimental control but fail to recapitulate the messy, diet-variable, immunologically complex environments in which human microbiomes actually operate. Dogs fill a genuine gap: their clinical diseases aren't induced artificially, their environment mirrors ours, and their shorter lifespans compress what would be decades of human aging into tractable study windows. The Dog Aging Project has already demonstrated this potential at scale.
However, this is a perspective review rather than primary data, so it synthesizes rather than generates evidence — a meaningful distinction. Critical limitations remain: no routine gnotobiotic canine systems exist to establish causality, breed and body-size heterogeneity demands careful stratification that many studies neglect, and reference databases for canine-specific microbial taxa remain incomplete. The degree of human-canine microbiome similarity also varies substantially depending on analytical method — a nuance often lost in headline claims. Practically, this framework is most valuable for hypothesis generation and for validating microbiome-disease associations before human intervention trials, not as a standalone causal platform.